ArticleAllergy and asthma proceedings2021
A 62-year-old man with new-onset bullae.
Article in Allergy and asthma proceedings, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 8 citations in OpenAlex.
- Integrating innovation and shared decision-making in allergy and immunology practice.Allergy and asthma proceedings · 2024Article
- Exploring the spectrum of allergic disorders that continue to challenge the Allergist-Immunologist: From hereditary angioedema to metal implant allergy.Allergy and asthma proceedings · 2024Article
- Bullous Herpes Zoster in a Lupus Nephritis Patient Treated with Rituximab: A Case Report.Acta medica Philippina · 2024Article
- Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs.Allergy and asthma proceedings · 2024Article
- Navigating the uncharted waters of chronic urticaria: A perplexing challenge for the allergist-immunologist.Allergy and asthma proceedings · 2023Article
- The challenge of neurologic disease for the allergist/immunologist.Allergy and asthma proceedings · 2023Article
- Hereditary angioedema again revisited.Allergy and asthma proceedings · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous blisters and/or bullae can occur in autoimmune disorders, infections, genetic diseases, and drug hypersensitivity. We present the case of a 62-year-old man with two autoimmune conditions who was admitted for antibiotic treatment of a lower extremity infection and suddenly developed a bullous rash. His physical examination was significant for tense, bullous lesions that involved his chin, palms, and inner thighs. Narrowing the differential diagnosis for patients with blistering skin lesions is imperative for timely and appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.